Your account is not claimed yet. You can sign up with ORCID to claim your account.

Mieke Van Hemelrijck (Mieke van Hemelrijck, M van Hemelrijck, Mieke V Hemelrijck, Mieke Van-Hemelrijck, M Van Hemelrijck)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 60

Top Venues

BJU international

BJUI compass

BMJ open

Acta oncologica (Stockholm, Sweden)

King's College London

King's College London (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

King's College London Sep 1o 2018

United Kingdom

Reader in Cancer Epidemiology :: Translational Oncology and Urology Research (TOUR)

Education History

King's College London Aug 18o 2008 - Nov 5o 2010

United Kingdom

PHD :: Division of Cancer Studies, Cancer Epidemiology Group

Publications

Gincy George, Beth Russell, Anne Rigg, Anthony C C Coolen, Mieke Van Hemelrijck
Real World Data Studies of Antineoplastic Drugs: How Can They Be Improved to Steer Everyday Use in the Clinic? Pragmatic and observational research 14 (2023)
William R C Knight, Jonathan L Moore, Greg P Whyte, Janine Zylstra, Andrew M Lane, James Pate, Louise Gervais-Andre, Nick Maisey, Mark Hill, Gemma Tham, Jesper Lagergren, Mark Kelly, Cara Baker, Mieke Van Hemelrijck, Vicky Goh, James Gossage, Mike Browning, Andrew R Davies
Prehabilitation exercise before oesophagectomy: long-term follow-up of patients declining/withdrawing from the program. The British journal of surgery (2023)
Gincy George, Hans Garmo, Jan Adolfsson, Kristin Elf, Rolf Gedeborg, Lars Holmberg, Pär Stattin, Johan Styrke, Mieke Van Hemelrijck
Use of Antiepileptic Drugs and Risk of Prostate Cancer: A Nationwide Case-Control Study in Prostate Cancer Data Base Sweden. Journal of oncology 2023 (2023)
Steven Maclennan, Lisa M Wintner, Katharina Beyer, Ailbhe Lawlor, Sheela Tripathee, Saeed Dabestani, Lorenzo Marconi, Rachel H Giles, Rose Woodward, Mieke Van Hemelrijck, Axel Bex, Patricia Zondervan
A protocol for the development of core outcome sets for effectiveness trials and clinical audits in renal cell cancer (R-COS). BJUI compass 4 (5) (2023)
Kathie Wong, Netty Kinsella, Jai Seth, David Nicol, Declan Cahill, Ramanathan Kasivisvanathan, John Withington, Masood Moghul, Charlotte Louise Moss, Mieke Van Hemelrijck, Kyriaki Giorgakoudi, Chris Cottrell, Emma Yates, Vincent Khoo, Nicholas D James
CO mparing Urolift and S tandard T ransurethral resection of prostate A head of R adiotherapy in men with urinary symptoms secondary to prostate enlargement in Southwest London and North Cumbria (CO-STAR): a study protocol for a randomised feasibility study. BMJ open 13 (10) (2023)
Louis Fox, Aida Santaolalla, Jasmine Handford, Richard Sullivan, Julie S Torode, Verna D Vanderpuye, Conjeevaram S Pramesh, Layth Mula-Hussain, Shaymaa AlWaheidi, Lydia E Makaroff, Ranjit Kaur, Clara Mackay, Deborah A Mukherji, Mieke Van Hemelrijck
Redefining Cancer Research Priorities in Low- and Middle-Income Countries in the Post-COVID-19 Global Context: A Modified Delphi Consensus Process. JCO global oncology 9 (2023)
Gincy George, Hans Garmo, Jan Adolfsson, Kristin Elf, Rolf Gedeborg, Lars Holmberg, Pär Stattin, Johan Styrke, Mieke Van Hemelrijck
Use of Antiepileptic Drugs and Risk of Prostate Cancer: A Nationwide Case-Control Study in Prostate Cancer Data Base Sweden. Journal of oncology 2023 (2023)
Abdulkarim Muhammad Iya, Katharina Beyer, Pinky Kotecha, Joyce Kibaru, Muzzammil Abdullahi, Sani Usman Alhassan, Muhammad Inuwa Mustapha, Abdullahi Ahmad, Yusuf Lawal, Jalo Rabiu Ibrahim, Aliyu Aminu, Aisha Abubakar, Abdullahi Saleh, Richard T Bryan, Mieke Van Hemelrijck, Beth Russell
Scoping review: bladder cancer in Nigeria - what are the gaps in clinical care and research? BMJ open 12 (3) (2022)
Kerri Beckmann, Declan Cahill, Christian Brown, Mieke Van Hemelrijck, Netty Kinsella
Developing a consensus statement for psychosocial support in active surveillance for prostate cancer. BJUI compass 4 (1) (2022)
Omar Eymech, Oliver Brunckhorst, Louis Fox, Anam Jawaid, Mieke Van Hemelrijck, Robert J Stewart, Prokar Dasgupta, Kamran Ahmed
An exploration of wellbeing in men diagnosed with prostate cancer undergoing active surveillance: a qualitative study. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 30 (6) (2022)
Theodora M Ripping, Elke Rammant, J A Witjes, Neil K Aaronson, Mieke Van Hemelrijck, L M C van Hoogstraten, null null, Lambertus A L M Kiemeney, Katja K H Aben
Validation and reliability of the Dutch version of the EORTC QLQ-BLM30 module for assessing the health-related quality of life of patients with muscle invasive bladder cancer. Health and quality of life outcomes 20 (1) (2022)
M Lavallee, T Yu, L Evans, Mieke Van Hemelrijck, C Bosco, A Golozar, A Asiimwe
Evaluating the performance of temporal pattern discovery: new application using statins and rhabdomyolysis in OMOP databases. BMC medical informatics and decision making 22 (1) (2022)
Rebecca Martin, Tessa Renouf, Jeannie Rigby, Shaista Hafeez, Ramesh Thurairaja, Pardeep Kumar, Susanne Cruickshank, Mieke Van Hemelrijck
Female sexual function in bladder cancer: A review of the evidence. BJUI compass 4 (1) (2022)
Beth Russell, Sarah Spencer-Bowdage, Jeannie Rigby, Jackie O'Kelly, Phil Kelly, Mark Page, Caroline Raw, Paula Allchorne, Peter Harper, Jeremy Crew, Roger Kockelbergh, Allen Knight, Mieke Van Hemelrijck, Richard T Bryan
The experience of UK patients with bladder cancer during the second wave of the COVID-19 pandemic. BJUI compass 3 (5) (2022)
Theodora M Ripping, Elke Rammant, J A Witjes, Neil K Aaronson, Mieke Van Hemelrijck, L M C van Hoogstraten, null null, Lambertus A L M Kiemeney, Katja K H Aben
Validation and reliability of the Dutch version of the EORTC QLQ-BLM30 module for assessing the health-related quality of life of patients with muscle invasive bladder cancer. Health and quality of life outcomes 20 (1) (2022)
Kerri Beckmann, Declan Cahill, Christian Brown, Mieke Van Hemelrijck, Netty Kinsella
Developing a consensus statement for psychosocial support in active surveillance for prostate cancer. BJUI compass 4 (1) (2022)
Theodora M Ripping, Elke Rammant, J A Witjes, Neil K Aaronson, Mieke Van Hemelrijck, L M C van Hoogstraten, null null, Lambertus A L M Kiemeney, Katja K H Aben
Validation and reliability of the Dutch version of the EORTC QLQ-BLM30 module for assessing the health-related quality of life of patients with muscle invasive bladder cancer. Health and quality of life outcomes 20 (1) (2022)
Rebecca Martin, Tessa Renouf, Jeannie Rigby, Shaista Hafeez, Ramesh Thurairaja, Pardeep Kumar, Susanne Cruickshank, Mieke Van Hemelrijck
Female sexual function in bladder cancer: A review of the evidence. BJUI compass 4 (1) (2022)
Hajer Hadi, Jasmine Handford, Beth Russell, Charlotte Louise Moss, Maria Jose Monroy-Iglesias, Elke Rammant, Sue Smith, Saoirse Olivia Dolly, Kiruthikah Thillai, Anne Rigg, Mieke Van Hemelrijck
Cancer staff in an NHS cancer center: infections, vaccination, stress and well-being support during the COVID-19 pandemic. Future oncology (London, England) 18 (18) (2022)
Maria Jose Monroy-Iglesias, Sonpreet Rai, Francesco A Mistretta, Graham Roberts, Harvey Dickinson, Beth Russell, Charlotte Moss, Rita De Berardinis, Matteo Ferro, Gennaro Musi, Christian Brown, Rajesh Nair, Ramesh Thurairaja, Archana Fernando, Paul Cathcart, Azhar Khan, Prokar Dasgupta, Sachin Malde, Marios Hadijpavlou, Saoirse Dolly, Kate Haire, Marta Tagliabue, Ottavio de Cobelli, Ben Challacombe, Mieke Van Hemelrijck
Impact of the COVID-19 pandemic on urological cancers: The surgical experience of two cancer hubs in London and Milan. BJUI compass 3 (4) (2022)
Katharina Beyer, Lisa Moris, Michael Lardas, Anna Haire, Francesco Barletta, Simone Scuderi, Eleni Vradi, Giorgio Gandaglia, Muhammad Imran Omar, Steven Maclennan, Jihong Zong, Bahman Farahmand, Sara J Maclennan, Zsuzsanna Devecseri, Alex Asiimwe, Laurence Collette, Anders Bjartell, James Ndow, Alberto Briganti, Mieke Van Hemelrijck, null null
Diagnostic and prognostic factors in patients with prostate cancer: a systematic review protocol. BMJ open 11 (2) (2021)
Rebecca K Bott, Gincy George, Ricardo McEwen, Janine Zylstra, William R C Knight, Cara R Baker, Mark Kelly, Nyree Griffin, Naami McAddy, Nick Maisey, Mieke Van Hemelrijck, James A Gossage, Jesper Lagergren, Andrew R Davies
Predicting response to neoadjuvant chemotherapy in patients with oesophageal adenocarcinoma. Acta oncologica (Stockholm, Sweden) 60 (12) (2021)
Rebecca K Bott, Kerri Beckmann, Janine Zylstra, Michelle J Wilkinson, William R C Knight, Cara R Baker, Mark Kelly, Nick Maisey, Justin Waters, Mieke Van Hemelrijck, Elizabeth C Smyth, William H Allum, Jesper Lagergren, James A Gossage, David Cunningham, Andrew R Davies
Adjuvant therapy following neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma in patients with clear resection margins. Acta oncologica (Stockholm, Sweden) 60 (5) (2021)
Beth Russell, Fredrik Liedberg, Oskar Hagberg, Anders Ullén, Karin Söderkvist, Viveka Ströck, Firas Aljabery, Truls Gårdmark, Tomas Jerlström, Amir Sherif, Lars Holmberg, Richard T Bryan, Deborah Enting, Mieke Van Hemelrijck
Risk of bladder cancer death in patients younger than 50 with non-muscle-invasive and muscle-invasive bladder cancer. Scandinavian journal of urology (2021)
Joyce Kibaru, Pinky Kotecha, Abdulkarim Muhammad Iya, Beth Russell, Muzzammil Abdullahi, Sani Usman Alhassan, Muhammad Inuwa Mustapha, Richard T Bryan, Mieke Van Hemelrijck
Scoping review protocol: bladder cancer in Nigeria: what are the gaps in clinical care and research? BMJ open 11 (1) (2021)
Gincy George, Hanna Vikman, Rolf Gedeborg, Ingela Franck Lissbrant, Hans Garmo, Johan Styrke, Mieke Van Hemelrijck, Pär Stattin
Risk of cardiovascular events in men on abiraterone or enzalutamide combined with GnRH agonists: nation-wide, population-based cohort study in Sweden. Acta oncologica (Stockholm, Sweden) 60 (4) (2021)
Beth Russell, Christel Häggström, Lars Holmberg, Fredrik Liedberg, Truls Gårdmark, Richard T Bryan, Pardeep Kumar, Mieke Van Hemelrijck
Systematic review of the association between socioeconomic status and bladder cancer survival with hospital type, comorbidities, and treatment delay as mediators. BJUI compass 2 (3) (2021)
Louis Fox, Harriet Wylie, Fee Cahill, Anna Haire, Saran Green, Joyce Kibaru, Catherine Hartley, Richard Sullivan, Mieke Van Hemelrijck
Gender Differences in Concerns About Participating in Cancer Research During the COVID-19 Pandemic. Cancer control : journal of the Moffitt Cancer Center 28 (2021)
Teresa Marsden, Derek J Lomas, Neil McCartan, Joanna Hadley, Steve Tuck, Louise Brown, Anna Haire, Charlotte Louise Moss, Saran Green, Mieke Van Hemelrijck, Ton Coolen, Aida Santaolalla, Elizabeth Isaac, Giorgio Brembilla, Douglas Kopcke, Francesco Giganti, Harbir Sidhu, Shonit Punwani, Mark Emberton, Caroline M Moore, null null
ReIMAGINE Prostate Cancer Screening Study: protocol for a single-centre feasibility study inviting men for prostate cancer screening using MRI. BMJ open 11 (9) (2021)
Mieke Van Hemelrijck, Vivienne Peters, John F Loong, Beth Russell, Louis Fox, Harriet Wylie, Aida Santaolalla, Katharina Beyer, Elke Rammant, E Lin, Anna Haire, Charlotte Moss, Saran Green
The importance of patient and public involvement in cancer research: time to create a new job profile. Future oncology (London, England) 17 (28) (2021)
S Green, S Tuck, J Long, T Green, A Green, P Ellis, A Haire, C Moss, F Cahill, N McCartan, L Brown, A Santaolalla, T Marsden, M Rodriquez Justo, J Hadley, S Punwani, G Attard, H Ahmed, C M Moore, M Emberton, Mieke Van Hemelrijck
ReIMAGINE: a prostate cancer research consortium with added value through its patient and public involvement and engagement. Research involvement and engagement 7 (1) (2021)
Miaoqi Chen, Ridesh Raj, Louis Fox, Charlotte Louise Moss, Gincy George, Sophia N Karagiannis, Deborah Enting, Magdalene Joseph, Nicola Peat, Beth Russell, Mieke Van Hemelrijck
Is there a role for physical activity when treating patients with cancer with immune checkpoint inhibitors? Protocol for a scoping review. BMJ open 11 (10) (2021)
Rebecca K Bott, K Beckmann, J Zylstra, M J Wilkinson, W R C Knight, C R Baker, M Kelly, N Maisey, A Qureshi, T Sevitt, Mieke Van Hemelrijck, Elizabeth C Smyth, W H Allum, J Lagergren, J A Gossage, D Cunningham, A R Davies, null null
Adjuvant therapy following oesophagectomy for adenocarcinoma in patients with a positive resection margin. The British journal of surgery 107 (13) (2020)
Beth Russell, Mieke Van Hemelrijck, Truls Gårdmark, Lars Holmberg, Pardeep Kumar, Andrea Bellavia, Christel Häggström
A mediation analysis to explain socio-economic differences in bladder cancer survival. Cancer medicine 9 (20) (2020)
Maria Jose Monroy-Iglesias, Beth Russell, Danielle Crawley, Naomi E Allen, Ruth C Travis, Aurora Perez-Cornago, Mieke Van Hemelrijck, Kerri Beckmann
Metabolic syndrome biomarkers and prostate cancer risk in the UK Biobank. International journal of cancer 148 (4) (2020)
Gincy George, Hans Garmo, Lucie-Marie Scailteux, Frédéric Balusson, Greet De Coster, Harlinde De Schutter, Josephina G Kuiper, Emmanuel Oger, Julie Verbeeck, Mieke Van Hemelrijck
Risk of cardiovascular disease following gonadotropin-releasing hormone agonists vs antagonists in prostate cancer: Real-world evidence from five databases. International journal of cancer 148 (9) (2020)
Sohail Singh, Preeti Sandhu, Kerri Beckmann, Aida Santaolalla, Kamal Dewan, Sharon Clovis, Jonah Rusere, Grace Zisengwe, Benjamin Challacombe, Christian Brown, Paul Cathcart, Rick Popert, Prokar Dasgupta, Mieke Van Hemelrijck, Oussama Elhage
Negative first follow-up prostate biopsy on active surveillance is associated with decreased risk of upgrading, suspicion of progression and converting to active treatment. BJU international 128 (1) (2020)
Liam Mannion, Cecilia Bosco, Rajesh Nair, Vinod Mullassery, Deborah Enting, Emma-Louise Jones, Mieke Van Hemelrijck, Simon Hughes
Overall survival, disease-specific survival and local recurrence outcomes in patients with muscle-invasive bladder cancer treated with external beam radiotherapy and brachytherapy: a systematic review. BJU international 125 (6) (2020)
Charlotte Moss, Saoirse Dolly, Beth Russell, Mary Lei, Sharmista Ghosh, Sophie Papa, Richard Sullivan, Mieke Van Hemelrijck, Anne Rigg, null null
One Piece of the Jigsaw for the Cancer Recovery Strategy: Prevalence of COVID-19 in Patients With Cancer. Cancer control : journal of the Moffitt Cancer Center 27 (3) (2020)
Guillaume Mouillet, Fabio Efficace, Antoine Thiery-Vuillemin, Emilie Charton, Mieke Van Hemelrijck, Francesco Sparano, Amélie Anota
Investigating the impact of open label design on patient-reported outcome results in prostate cancer randomized controlled trials. Cancer medicine 9 (20) (2020)
Katharina Beyer, Mieke Van Hemelrijck, Netty Kinsella, Ravi Barod
How does COVID-19 impact treatment decision-making for clinicians in localised kidney cancer. BJUI compass (2020)
Sarah Spencer-Bowdage, Beth Russell, Jeannie Rigby, Jackie O'Kelly, Phil Kelly, Mark Page, Caroline Raw, Paula Allchorne, Peter Harper, Jeremy Crew, Roger Kockelbergh, Allen Knight, Mieke Van Hemelrijck, Richard T Bryan
The experience of UK patients with bladder cancer during the COVID-19 pandemic: a survey-based snapshot. BJU international 127 (2) (2020)
Mario De Piano, Valeria Manuelli, Giorgia Zadra, Massimo Loda, Gordon Muir, Ash Chandra, Jonathan Morris, Mieke Van Hemelrijck, Claire M Wells
Exploring a role for fatty acid synthase in prostate cancer cell migration. Small GTPases 12 (4) (2020)
Abdullatif Aydın, Kamran Ahmed, Mieke Van Hemelrijck, Hashim Uddin Ahmed, Muhammad Shamim Khan, Prokar Dasgupta, null null
Simulation in Urological Training and Education (SIMULATE): Protocol and curriculum development of the first multicentre international randomized controlled trial assessing the transferability of simulation-based surgical training. BJU international 126 (1) (2020)
Mieke Van Hemelrijck, Francesco Sparano, Lisa Moris, Katharina Beyer, Francesco Cottone, Mirjam Sprangers, Fabio Efficace
Harnessing the patient voice in prostate cancer research: Systematic review on the use of patient-reported outcomes in randomized controlled trials to support clinical decision-making. Cancer medicine 9 (12) (2020)
Mieke Van Hemelrijck
The burden of urological cancers in low- and middle-income countries. BJU international 123 (4) (2019)
Mieke Van Hemelrijck
Occupational exposure and risk of testicular cancer: what can an ecological study in the Nordic countries tell us? BJU international 122 (3) (2019)
David L Robinson, Hans Garmo, Mieke Van Hemelrijck, Jan-Erik Damber, Ola Bratt, Lars Holmberg, Lars-Olof Wahlund, Pär Stattin, Jan Adolfsson
Androgen deprivation therapy for prostate cancer and risk of dementia. BJU international 124 (1) (2019)
Sam Sollie, Dominique S Michaud, Debashis Sarker, Sophia N Karagiannis, Debra H Josephs, Niklas Hammar, Aida Santaolalla, Goran Walldius, Hans Garmo, Lars Holmberg, Ingmar Jungner, Mieke Van Hemelrijck
Chronic inflammation markers are associated with risk of pancreatic cancer in the Swedish AMORIS cohort study. BMC cancer 19 (1) (2019)
Sneha Mehrotra, Megan Rowland, Hanyu Zhang, Beth Russell, Louis Fox, Katharina Beyer, Elke Rammant, Nicola Peat, Mieke Van Hemelrijck, Cecilia Bosco
Scoping review protocol: is there a role for physical activity interventions in the treatment pathway of bladder cancer? BMJ open 9 (11) (2019)
Gincy George, Hans Garmo, Sarah Rudman, Lars Holmberg, David Robinson, Pär Stattin, Jan Adolfsson, Mieke Van Hemelrijck
Long-term adherence to GnRH agonists in men with prostate cancer. A nation-wide population-based study in prostate cancer data base Sweden. Scandinavian journal of urology 54 (1) (2019)
William R C Knight, C Yip, W Wulaningsih, A Jacques, N Griffin, J Zylstra, Mieke Van Hemelrijck, N Maisey, A Gaya, C R Baker, M Kelly, J A Gossage, J Lagergren, D Landau, V Goh, A R Davies, null null, S Ngan, A Qureshi, H Deere, M Green, F Chang, U Mahadeva, B Gill-Barman, S George, J Dunn, S Zeki, J Meenan, O Hynes, G Tham, C Iezzi
Prediction of a positive circumferential resection margin at surgery following neoadjuvant chemotherapy for adenocarcinoma of the oesophagus. BJS open 3 (6) (2019)
Anna Kessler, Sam Sollie, Ben Challacombe, Karen Briggs, Mieke Van Hemelrijck
The global prevalence of erectile dysfunction: a review. BJU international (2019)
Mieke Van Hemelrijck, Francesco Sparano, Debra Josephs, Mirjam Sprangers, Francesco Cottone, Fabio Efficace
Patient-reported outcomes in randomised clinical trials of bladder cancer: an updated systematic review. BMC urology 19 (1) (2019)
Nicholas Tobias Johannes Raison, Kamran Ahmed, Takashige Abe, Oliver Brunckhorst, Giacomo Novara, Nicolò Buffi, Craig McIlhenny, Henk van der Poel, Mieke Van Hemelrijck, Andrea Gavazzi, Prokar Dasgupta
Cognitive training for technical and non-technical skills in robotic surgery: a randomised controlled trial. BJU international 122 (6) (2018)
Mieke Van Hemelrijck
Human development and its impact on genitourinary cancers. BJU international 120 (6) (2018)
Andrew R Davies, D Myoteri, J Zylstra, C R Baker, W Wulaningsih, Mieke Van Hemelrijck, N Maisey, W H Allum, E Smyth, J A Gossage, J Lagergren, D Cunningham, M Green, null null
Lymph node regression and survival following neoadjuvant chemotherapy in oesophageal adenocarcinoma. The British journal of surgery 105 (12) (2018)
William R C Knight, J Zylstra, W Wulaningsih, Mieke Van Hemelrijck, D Landau, N Maisey, A Gaya, C R Baker, J A Gossage, J Largergren, Andrew R Davies, null null
Impact of incremental circumferential resection margin distance on overall survival and recurrence in oesophageal adenocarcinoma. BJS open 2 (4) (2018)
Sophie M Bruinsma, Liying Zhang, Monique J Roobol, Chris H Bangma, Ewout W Steyerberg, Daan Nieboer, Mieke Van Hemelrijck, null null
The Movember Foundation's GAP3 cohort: a profile of the largest global prostate cancer active surveillance database to date. BJU international 121 (5) (2018)
Cecilia Bosco, Chloe Wong, Hans Garmo, Danielle Crawley, Lars Holmberg, Niklas Hammar, Jan Adolfsson, Pär Stattin, Mieke Van Hemelrijck
Drugs for metabolic conditions and prostate cancer death in men on GnRH agonists. BJU international 121 (2) (2017)

Mieke Van Hemelrijck.css-eqlu8i{font-size:small;padding-left:4px;} (Mieke van Hemelrijck, M van Hemelrijck, Mieke V Hemelrijck, Mieke Van-Hemelrijck, M Van Hemelrijck)

Publication Activity (10 Years)

Top Topics

Top Venues

Mieke Van Hemelrijck (Mieke van Hemelrijck, M van Hemelrijck, Mieke V Hemelrijck, Mieke Van-Hemelrijck, M Van Hemelrijck)